Selected Advanced Solid Tumors clinical trials

Explore recruiting selected advanced solid tumors clinical trials.

Recruiting selected advanced solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Selected Advanced Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1 Trial of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Activity of RP-1664 in Participants with Advanced Solid Tumors

Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination with Irinotecan in Pretreated Patients with Selected Advanced Solid Tumors

Spain, France, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A First-in-Human, Open-label, Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects with Advanced Cancers

Spain, Poland

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM14 in Combination with Irinotecan in Pretreated Patients with Selected Advanced Solid Tumors

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

An open label phase II platform modular study exploring the efficacy and safety of the Valemetostat (EZH1/2 inhibitor) in patients with selected solid tumors (EZHiSWITCH)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Selected Advanced Solid Tumors trials by city

Selected Advanced Solid Tumors clinical trials

Recruiting selected advanced solid tumors studies right now

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

A Study of YL202 in Patients With Advanced Solid Tumors

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

Clinical Trial of PM54 in Advanced Solid Tumors Patients.